Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial.

Yulug B., Altay O., Li X., Hanoglu L., Cankaya S., Velioglu H. A., ...Daha Fazla

Brain communications, cilt.7, sa.1, 2025 (ESCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 1
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1093/braincomms/fcae478
  • Dergi Adı: Brain communications
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Psycinfo, Directory of Open Access Journals
  • İstanbul Medipol Üniversitesi Adresli: Evet